Nanōmix eLab® COVID-19 Rapid IgG/IgM Panel

Available Now




Rapid Testing for COVID-19

  • For Use in Compliance with FDA Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency
  • Validated. Request for Emergency Use Authorization submitted to FDA July 2020
  • Results in 10 minutes

The Nanōmix eLab® COVID-19 Rapid IgG/IgM Panel is an electrochemical immunoassay test intended for qualitative detection (presence/absence) of IgG and IgM antibodies to SARS-CoV-2 in human venous whole blood and plasma (K2EDTA, lithium-heparin, sodium-heparin, sodium citrate). Results are for the detection of SARS CoV-2 antibodies. IgG and IgM antibodies to SARS-CoV-2 are generally detectable in blood several days after initial infection, although the duration of time antibodies are present post-infection is not well characterized. Results from antibody testing should not be used to diagnose or exclude acute SARS-COV-2 infection.

Covid 19 testing

Rapid  Testing for COVID-19 coronavirus point-of-care testing

Download IFU - Instructions For Use
(requires site registration)


Contact us here if you are interested in more information about eLab® testing and how to purchase.

image verification